These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23610808)

  • 1. For patients who inherit homozygous familial hypercholesterolemia, 2 new treatments available.
    Morrow T
    Manag Care; 2013 Mar; 22(3):47-8. PubMed ID: 23610808
    [No Abstract]   [Full Text] [Related]  

  • 2. Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder.
    Smith RJ; Hiatt WR
    JAMA Intern Med; 2013 Sep; 173(16):1491-2. PubMed ID: 23649296
    [No Abstract]   [Full Text] [Related]  

  • 3. Two new drugs for homozygous familial hyperchelesterolemia.
    Med Lett Drugs Ther; 2013 Apr; 55(1413):25-7. PubMed ID: 23545581
    [No Abstract]   [Full Text] [Related]  

  • 4. Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia.
    Rader DJ; Kastelein JJ
    Circulation; 2014 Mar; 129(9):1022-32. PubMed ID: 24589695
    [No Abstract]   [Full Text] [Related]  

  • 5. Lomitapide and mipomersen: novel lipid-lowering agents for the management of familial hypercholesterolemia.
    Dixon DL; Sisson EM; Butler M; Higbea A; Muoio B; Turner B
    J Cardiovasc Nurs; 2014; 29(5):E7-E12. PubMed ID: 24231894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy briefs.
    Philippidis A
    Hum Gene Ther; 2012 Dec; 23(12):1221-3. PubMed ID: 23234557
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial hypercholesterolaemia: new treatment options.
    Ezzahti M; Sijbrands EJ; Mulder MT; Roeters van Lennep JE
    Neth J Med; 2013 Jun; 71(5):227-33. PubMed ID: 23799308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering treatment for homozygous familial hypercholesterolaemia.
    Santos RD
    Lancet; 2013 Apr; 381(9873):1182. PubMed ID: 23561997
    [No Abstract]   [Full Text] [Related]  

  • 9. A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.
    Yoshida H
    J Atheroscler Thromb; 2017 Apr; 24(4):390-392. PubMed ID: 28239069
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel therapies for treating familial hypercholesterolemia.
    Bandeali SJ; Daye J; Virani SS
    Curr Atheroscler Rep; 2014 Jan; 16(1):382. PubMed ID: 24293346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review.
    Neef D; Berthold HK; Gouni-Berthold I
    Expert Rev Clin Pharmacol; 2016; 9(5):655-63. PubMed ID: 26943823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lomitapide.
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):347-52. PubMed ID: 21846156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is mipomersen ready for clinical implementation? A transatlantic dilemma.
    Sjouke B; Balak DM; Beuers U; Ratziu V; Stroes ES
    Curr Opin Lipidol; 2013 Aug; 24(4):301-6. PubMed ID: 23759796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B].
    Alonso R; Mata P; Alonso Y Gregorio M; de Andrés R
    Med Clin (Barc); 2015 Sep; 145(5):229-30. PubMed ID: 25543225
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost of simvastatin therapy in treatment of hypercholesterolaemia in a hospital lipid clinic.
    Lepre F; Lee E
    Med J Aust; 1992 Apr; 156(7):510. PubMed ID: 1556987
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report: The efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child.
    Chacra APM; Ferrari MC; Rocha VZ; Santos RD
    J Clin Lipidol; 2019; 13(3):397-401. PubMed ID: 30948303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
    Blom DJ; Averna MR; Meagher EA; du Toit Theron H; Sirtori CR; Hegele RA; Shah PK; Gaudet D; Stefanutti C; Vigna GB; Larrey D; Bloedon LT; Foulds P; Rader DJ; Cuchel M
    Circulation; 2017 Jul; 136(3):332-335. PubMed ID: 28716835
    [No Abstract]   [Full Text] [Related]  

  • 18. New pharmacologic treatments for familial hypercholesterolemia.
    McDonough A; Matura LA; Carroll D
    Nurs Womens Health; 2013 Oct; 17(5):443-7. PubMed ID: 24138664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolocumab approved for reducing LDL cholesterol.
    Traynor K
    Am J Health Syst Pharm; 2015 Oct; 72(19):1599-600. PubMed ID: 26386095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coronary artery bypass graft in adolescent suffering from homozygous familial hypercholesterolemia resistant to probucol therapy].
    Ayegnon KG; Morcos KK; Yangni-Angate KH; Ahmed-Nasr M
    Mali Med; 2009; 24(2):62-4. PubMed ID: 19666374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.